(Q36394357)

13 August 2017

1 reference

title

A constellation of complications: the metabolic syndrome (English)

1 reference

13 August 2017

1 reference

Scott M Grundy

1

1 reference

13 August 2017

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

7

1 reference

13 August 2017

2-3

1 reference

13 August 2017

36-45

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

Obesity and the metabolic syndrome in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

State of the heart in the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

New approaches in the intensive management of cardiovascular risk in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

The metabolic syndrome: a practical guide to origins and treatment: Part II.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

Rimonabant: unique and promising

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

New therapeutic options for the metabolic syndrome: what's next?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980066-3

7 January 2021

10.1016/S1098-3597(05)80066-3

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16473259